Education
About Us
Working with TipRanks
Follow Us
Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY
The following ETFs maintain exposure to Alnylam Pharma (ALNY). ETF holdings data are updated once a day, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
407 ETFs Hold Alnylam Pharma (ALNY)
Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in ALNY |
|---|---|---|---|---|---|---|
| JPMorgan ActiveBuilders U.S. Large Cap Equity ETF | $28.12M | 0.17% | 7.81% | $11.58K | <0.01% | |
| Lyxor MSCI World Communication Services TR UCITS ETF | $6.37M | 0.30% | 7.17% | $1.93M | <0.01% | |
| VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD | $4.40M | 0.35% | 5.86% | $263.05K | <0.01% | |
| Tema Neuroscience and Mental Health ETF | $9.39M | 0.75% | 5.06% | $475.70K | <0.01% | |
| Selectra Investments SICAV - J. Lamarck Biotech | $263.98K | 3.36% | 4.66% | $2.90M | <0.01% | |
| Horizon Kinetics Medical ETF | $14.69M | 0.85% | 4.61% | $691.23K | <0.01% | |
| Global X Genomics & Biotechnology UCITS ETF | $7.16M | 0.60% | 4.53% | $326.65K | <0.01% | |
| Global X Genomics & Biotechnology ETF | $45.91M | 0.50% | 4.53% | $2.13M | <0.01% | |
| VanEck Biotech ETF | $338.11M | 0.35% | 4.27% | $14.52M | 0.05% | |
| VictoryShares Nasdaq Next 50 ETF | $17.98M | 0.18% | 3.64% | $663.82K | <0.01% |
